Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
8.02
-0.51 (-5.98%)
At close: Aug 20, 2026, 4:00 PM EDT
8.16
+0.14 (1.75%)
After-hours: Aug 20, 2026, 7:30 PM EDT
Achieve Life Sciences Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Achieve Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $13.83. The average 1-year stock price forecast is 72.44% higher than the current stock price, while the lowest is $9.00 (+12.22%) and the highest is $21 (+161.85%).
Price Target: $13.83 (+72.44%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Achieve Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 7 | 7 | 8 |
| Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 9 | 9 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $17 | Buy | Maintains | $17 | +111.97% | Aug 15, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $10 | Buy | Maintains | $10 | +24.69% | Aug 13, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $13 | Buy | Initiates | $13 | +62.09% | Aug 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $13 | Buy | Reiterates | $13 | +62.09% | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +49.63% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
41.33M
EPS This Year
-1.37
from -1.25
EPS Next Year
-0.64
from -1.37
EPS and Forward PE are based on non-GAAP adjusted numbers.